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Neuropsychological research poses several challenges. Some of these, such as developing 
new ideas and conducting innovative studies, are approached with great enthusiasm, and are 
an integral and motivating part of academic research. By contrast, other challenges feel like 
gruelling, near-impossible tasks, designed to test the will of would-be researchers. For many, 
the process of obtaining UK National Health Service (NHS) ethics approval is the archetypal 
example of such a task. Baron (this issue) highlights several of the difficulties concerning the 
ethical review of research involving human subjects, identifying flaws in the current system, 
and their negative impact on the research process. In this commentary we further reflect on 
the current system for gaining ethics approval to work with brain-injured patients in the UK, 
and its implications for neuropsychology research in the UK and beyond. 
  
What is the Declaration of Helsinki for and why was it devised? 
The Declaration of Helsinki was originally developed for the medical community by the 
World Medical Association (WMA) in June 1964 in Helsinki, Finland as a set of ethical 
principles regarding human experimentation. Since 1964, it has undergone seven revisions 
expanding in length from 11 paragraphs to 37 in the 2013 version, reflecting both continual 
developments as well as clarifications that are needed.  
 
Why is this Declaration important to neuropsychologists? 
As neuropsychologists, we work with brain-injured patients for a variety of reasons including 
(but not exclusively) to gain a better understanding of intact functions, to improve assessment 
of other patients, and finally to develop rehabilitation to allow post-injury readjustment. To 
allow us to perform these various aspects of our work, having a trusting relationship with our 
patients (who to all intents and purposes are highly vulnerable due to their neurological 
limitations such aphasia, confusion, and information processing difficulties) is of paramount 
importance.We are bound by the same duty of care as medical staff and this duty is a vital 
aspect of our practice both by training and by professional registration. Furthermore, patients 
and their relatives have the right to be correctly informed about all relevant aspects of the 
research, possible implications for their health (if any) and right to decline participation. 
Therefore,having clear Ethics rules is not just a mandatory aspect for modern research, it is 
also a useful support to reach better research outcomes and protect patients from any form of 
possible abuse.  
 
How do we feel about the NHS’s interpretation of the Declaration of Helsinki?  
There is a consensus that, while the neuropsychology community firmly believes in 
protecting the rights of our research patients, the processes required to gain NHS approval 
have become more and more complex over the years, as a consequence of historical events 
that may have little to do with neuropsychology. For example, it was discovered in 1999 that 
Alder Hey Hospital in Liverpool had been systematically harvesting the organs of deceased 
babies without the knowledge or consent of the bereaved parents. This appalling scandal 
resulted in a number of recommendations for research within the NHS. Despite this 
completely understandable response, it may have led to a knee-jerk reaction to anything 
involving ‘patients’. An analogous situation can be found in the domain of aviation safety: 
following the discovery that would-be terrorist and suicide-bomber Richard Reid had 
attempted to take liquid explosives onto a plane inside his shoe, millions of people around the 
world are now barred from taking liquids onto planes unless they are in very small bottles. 
Although these regulations may not actually prevent harm, airline security is seen to be doing 
something. Quite possibly medical research ethics is similarly driven by being seen to do 
something/anything, without being quite clear in its purpose. A culture has developed in 
which we busy ourselves with being seen to protect patients from opportunistic, misguided 
and misleading scientists who are in fact operating with great integrity in line with their codes 
of practice. As a result, neuropsychologists have been saddled with working within a system 
that is largely irrelevant and unnecessary. Most of the work that we do is non-invasive, 
mainly consisting of behavioural studies with paper-and-pencil or computer tasks. Apart from 
the length of time spent completing these largely innocuous assessments, which constitute 
minimal (everyday) risk (similar to that which could happen by watching TV), there is 
negligible risk to the patient’s well-being. On the contrary, several patients are genuinely 
interested in taking part in our studies, as their participation allows them to reframe their 
difficulties into a new scientific perspective, and to consider their condition as a potential 
resource for themselves and the community. However, NHS ethics review tend to adopt the 
most stringent criterion, without discriminating between high- and minimal-risky 
methodology. This approach typically involves elaborate justification of the minutia of a 
proposed study, which then needs to be assessed and evaluated on its merit. Researchers are 
burdened with endless requests of compliance to the rules of the game, even if quite removed 
from its actual purpose.  A myriad of communication difficulties between the different 
disciplines makes the process protracted and demanding. All this time we are not actually 
producing anything at all - no novel insight, no scientific progression, and quite possibly not 
even safer research conditions. This is no self-assessment process for responsible 
professionals. This is a culture of imposing scrutiny and standing guard. 
 
What are the implications of the 'more is ridiculous' in the current framework for 
getting NHS approval?  
There are a number of implications of what we feel is a misplaced ethical procedure that has 
been imposed upon neuropsychologists in the name of protecting patients. The procedures are 
extremely lengthy and often require documentation that has little relevance to the patient and 
the care with which we work with them. These lengthy processes have financial implications 
because of the sheer time that it takes to complete, review, and administrate the extensive 
documentation. Furthermore, despite having one national medical research ethics procedure 
that in its draconian format covers all practices and all eventualities, significant fragmentation 
and duplication persists around research governance when recruiting clinical populations 
from different regional health trusts. This non-harmonised layer of bureaucracy results in 
much duplication and wildly varying governance requirements as different sites seem to have 
different local policies about a large variety of issues from recruitment modality to format of 
the information sheets, forcing further amendments of largely redundant documentation.  
This incredible amount of redundancy, repeating the same lengthy procedure multiple times, 
has financial implications again for the time of the researchers, and therefore for the 
Universities, NHS, administrators and review panel members. At some levels, the analogy 
with the implications of the lone-wolf shoe-bomber is complete, because one man’s act has 
resulted in an unnecessarily lengthy and complicated procedure for research which has 
minimal (if any) risk. Just as flying to a destination has been made more difficult, alternative 
methods of transport (e.g. Eurostar to Paris) have become more attractive, in a parallel 
manner, despite firmly believing in the Declaration of Helsinki, many neuropsychologists 
feel that the NHS system is a disincentive to conducting the research that they are passionate 
about. 
 
How do other countries do things?  
As one of the working groups tasked by the British Neuropsychological Society to consider 
the challenges of neuropsychological research ethics, we surveyed the challenges faced by 
colleagues in other countries. We communicated with neuropsychological researchers from 
Belgium, France, Germany, The Netherlands, Sweden, Italy, Greece, Israel, the USA, India, 
Japan, New Zealand and South Africa. What was strikingly evident from this exercise was 
that all struggled with many of the same issues. All researchers’ productivity seemed to be 
burdened by ethics procedures that were not designed for the nature of our research. Some 
seem to have it easier than their colleagues in other countries, while others considered 
moving their research across the border to countries where procedures appeared to them to be 
more light-touch. The general themes of dissatisfaction were around insurance or indemnity, 
poor fit of neuropsychological research with medical research ethical procedures, needing to 
reapply or notify when making small changes to the research that do not actually affect the 
ethical principles, and seemingly incommensurable differences in understanding between 
disciplines.  
 
It occurred to us that it is the unusual open-ended nature of neuropsychological research that 
may make these challenges so universal. Our research is often data-driven. The fact that our 
methods do not actually vary much, and therefore the ethical issues hardly requiring constant 
re-examining, does not seem to satisfy those who stand guard. Details, in the name of 
protocol, need to be spelled out even before they are known. Our need for flexibility is 
regarded with much suspicion due to a lack of trust which seems to run across international 
borders. In summary, it was sadly not possible to identify one country or ethics system that 
could be taken as a best-practice model. Neuropsychologists internationally struggle with the 
same issues. 
 
What do we propose as a way forward? A case of when ‘less is more’….  
As a community within the British Neuropsychological Society, we have Fellows of the Royal 
Society, members of major research panels, and medical doctors. Within our community therefore, 
there is a plethora of expertise that can be used to police our ethical procedures. At the moment, the 
Research Ethical Committees (REC) process in the UK offers the possibility of considering 
applications for a short process called ‘proportionate review’. However, often neuropsychological 
studies are not considered eligible for this fast-track process as the panels consider that our studies 
present medical issues. It would be useful to resolve any perceived differences in what constitutes 
‘minimal (everyday) risk’, most likely covering a large proportion of neuropsychological research. 
Once such understanding has been established, this would allow for more proportional ethical review 
that could be more local and furthermore make insurance of risk much more straightforward. 
 
We mentioned above the lack of fit between the nature of neuropsychological research and medical 
ethics practice. In our non-interventionist basic behavioural research, we tend to use a very specific 
set of methodologies that does not actually vary much between the different research projects which 
nevertheless require individual ethical approval. A disconnect arises from patient ethics that is 
designed for medical trials. In ourbasic science work we generally have no set protocol with outcome 
measures assessed at fixed time points In contrast to group studies where all aspects of the research 
are planned, (multiple) single case studies are more open-ended and lists of tests and experimental 
tasks cannot be predefined a priori. This is data-driven research where the next step in the research 
process is based on what we find patient can and cannot do on tasks that have been designed to 
answer each question in turn, making minor procedural adjustment to address the next questions. . But 
importantly with regards to ethics, our methods do not change much as we progress in research 
programmes and patients’ right of informed consent is not undermined. What would be very useful 
therefore is and alternative ethical approval path for basic science for group and single case studies in 
neuropsychology. The often generic methods used in a research programme would be described (the 
things participating patients would do, and the things they would never do) and the scientific merit of 
a number of broader basic research questions would be clearly demonstrated. This would then form a 
generic approval for a broad research programme that would be awarded ethical approval for a period 
of, say, ten years. This would be a real cost-saving, and would aid publically funded research 
productivity in neuropsychology; the Declaration of Helsinki would be firmly adhered whilst 
benefitting both patients and society’s understanding of the brain. 
  
